Human Papillomavirus

HPV vaccine's hypersensitivity reactions are rare
Hypersensitivity reactions to the quadrivalent HPV vaccine (4vHPV, Gardasil) are uncommon and most schoolgirls can tolerate subsequent doses, finds the first evaluation of the quadrivalent HPV vaccine published on bmj.com.

Gardasil HPV vaccine prevented genital lesions in men
GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) Vaccine, Recombinant], the cervical cancer vaccine from Merck & Co., Inc., prevented 90 percent of external genital lesions caused by human papillomavirus (HPV) types 6, 11, 16 and 18 in a pivotal Phase III study in men aged 16 to 26.

New MRI imaging may identify cervical cancer early
Using high-resolution magnetic resonance imaging (MRI) with a special vaginal coil, a technique to measure the movement of water within tissue, researchers may be able to identify cervical cancer in its early stages, according to a new study being published in the November issue of Radiology.

Gardasil vaccine to prevent cervical cancer in India
MSD Pharmaceuticals India announced the launch of GARDASIL Vaccine, India's first vaccine to help prevent Cervical Cancer caused by the HPV.

QIAGEN's careHPV test provides more accurate screening
A new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.

HPV vaccine Cervarix in UK's immunisation programme
The UK's leading cervical cancer charity, Jo's Trust, has welcomed the UK's Department of Health's announcement that the HPV vaccine, Cervarix will be used in the national immunisation programme for 12/13 year olds starting in September, 2008.

Persistent HPV infection raises cervical cancer risk
Persistent infection with human papillomavirus (HPV) could be a useful clinical marker for increased risk of cervical cancer, the second most common cancer in women worldwide, revealed by researchers from the University of North Carolina at Chapel Hill.

Mothers less likely to vaccinate daughters against HPV
U.S. mothers report they are less likely to vaccinate daughters under age 13 against human papillomavirus virus (HPV), even though the vaccine is recommended for girls at age 11 and 12, it's incumbent upon the healthcare community to work to improve mom's acceptance of the vaccination for younger daughters, say researchers at Cincinnati Children's Hospital Medical Center who conducted the study.

Alarming rates of STDs among teenage girls
A US study found that one in four teenage girls aged 14 to 19 has a sexually transmitted disease (STD). Nearly half the African-Americans in the study were infected by one of the diseases. The survey, part of the National Health and Nutrition Examination Survey, did not ask about syphilis or gonorrhea, so it is likely the STD rates are actually higher.

Gardasil HPV vaccine reduces abnormal pap test results
A significant drop in abnormal Pap test results happened after girls and women were given Gardasil vaccine to prevent cervical cancer, according to a researcher at the University of Alabama at Birmingham (UAB).

Stress may increase cervical cancer risk
A woman's daily stress can reduce her ability to fight off a common sexually transmitted disease and increase her risk of developing the cancer it can cause, according to a new study. No such association is seen, however, between past major life events, such as divorce or job loss, and the body's response to the infection.

Tattooing improves DNA vaccine response
Tattooing is a more effective way of delivering DNA vaccines; a tattoo can be more than just a fashion statement – it has potential medical value, according to an article published in the online open access journal, Genetic Vaccines and Therapy.

New strategies work to put cancer on the firing line
Dr. Yukai He wants to put cancer in the bull's eye. "Cancer really comes from us," the Medical College of Georgia Cancer Center immunologist says of the scary reality that cancer cells are our own cells gone awry. That means our immune system doesn't always see cancer as a horrific invader.

Mouth rinse gargle test for cancer
A morning gargle could someday be more than a breath freshener – it could spot head and neck cancer, say scientists at the Johns Hopkins Kimmel Cancer Center. Their new study of a mouth rinse that captures genetic signatures common to the disease holds promise for screening those at high risk, including heavy smokers and alcohol drinkers.

Mission
Health Newstrack is dedicated to serve recent and updated health news & medical research, events/news, views/reviews to its subscribers and free access to general public, health & medical professionals, and other health seekers worldwide online with a user-friendly system.
Bookmark this page
Health News Track is tracking world's medical health news daily.

Add to Google
Add health news article to: Digg | Del.icio.us | Newsvine | Reddit | Fark | Yahoo | Technorati | RSS
The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.
We comply with the HONcode principles for trustworthy health information, verify here.
www.healthnewstrack.com - About us, Editorial team, Advertising, Jobs, Links, Privacy policy, Disclaimer, Feedback,
Site map, List health news, Health news organizations, Health news world, Accessibility, Glossary, Testimonials, Blog
Mobile/PDA Submit press release
© 2007-2008 HealthNewstrack.com
Track Health News Daily
2.09